Etoposide Injection 100 mg/5 mL (1)

Pajjiż: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

etoposide, Quantity: 20 mg/mL

Disponibbli minn:

Pfizer (Perth) Pty Ltd

INN (Isem Internazzjonali):

Etoposide

Għamla farmaċewtika:

Injection, intravenous infusion

Kompożizzjoni:

Excipient Ingredients: macrogol 300; citric acid; polysorbate 80; ethanol absolute

Rotta amministrattiva:

Intravenous

Unitajiet fil-pakkett:

5 mL x 1, 5 mL x 10

Tip ta 'preskrizzjoni:

(S1) This Schedule is intentionally blank

Indikazzjonijiet terapewtiċi:

- Small cell carcinoma of the lung. - Acute monocytic and myelomonocytic leukaemia. - Hodgkin's Disease - Non-Hodgkin's Lymphoma.

Sommarju tal-prodott:

Visual Identification: Clear, colourless to straw coloured solution, free from visible particles.; Container Type: Vial; Container Material: PP; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

L-istatus ta 'awtorizzazzjoni:

Licence status A

Data ta 'l-awtorizzazzjoni:

2016-12-02